James J Moon

James J Moon

Department of Pharmaceutical Sciences, University of Michigan

Affiliated withUniversity of Michigan

Research Area

Biography

James J Moon has not added Biography.
If you are James J Moon and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Publication title

Cited by 13

2015

Other Publications

Article
Year
Differential Regulation of Fcgamma Receptor Isoforms: Implications for Therapeutic Intervention.

American journal of therapeutics| PubMed ID: 11854786

1995
2003
2004
2005
2005
2005
2005
2006
2006
2007
2007
2007
2007
2008
2008
2008
Antigen persistence is required for dendritic cell licensing and CD8+ T cell cross-priming.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 18713977

2008
2009
EphrinA I-targeted nanoshells for photothermal ablation of prostate cancer cells.

International journal of nanomedicine| PubMed ID: 18990944

2008
2009
2009
Tracking epitope-specific T cells.

Nature protocols| PubMed ID: 19373228

2009
Tracking the dynamics of salmonella specific T cell responses.

Current topics in microbiology and immunology| PubMed ID: 19521686

2009
Positive selection optimizes the number and function of MHCII-restricted CD4+ T cell clones in the naive polyclonal repertoire.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 19541603

2009
2009
2010
2010
2010
2010
2010
Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 20962277

2010
2011
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 21820024

2011
Quantitative impact of thymic selection on Foxp3+ and Foxp3- subsets of self-peptide/MHC class II-specific CD4+ T cells.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 21873213

2011
2011
CARMA1 is necessary for optimal T cell responses in a murine model of allergic asthma.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 22075698

2011
Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 22247289

2012
2012
2012
2012
2011
Engineering nano- and microparticles to tune immunity.

Advanced materials (Deerfield Beach, Fla.)| PubMed ID: 22641380

2012
2012
2012
2013
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 23933525

2013
2013
2013
2014
Biomaterials for nanoparticle vaccine delivery systems.

Pharmaceutical research| PubMed ID: 24848341

2014
2015
Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 25869965

2015